Status:
COMPLETED
Clinico-demographic Profile of the Patient With Pancreaticobiliary Malignancy Undergoing ERCP in a Tertiary Care Center of Nepal
Lead Sponsor:
Kathmandu University School of Medical Sciences
Conditions:
Cholangiocarcinoma
Bile Duct Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Background Pancreaticobiliary malignancy (PBM) is a group of cancers affecting pancreas and bile duct. The diagnosis is often late and with fatal outcomes. Here, investigators study the clinicodemogra...
Eligibility Criteria
Inclusion
- above 18years of age.
- those with confirmed pancreaticobiliary malignancies, diagnosed through histopathology from ERCP, or Endoscopic Ultrasound (EUS), or Computerized tomography (CT) guided biopsy, and who underwent ERCP
- those with strong suspicions of malignancy confirmed by clinical, CT scan and ERCP findings, and who also underwent ERCP
Exclusion
- those with suspected intrahepatic cholangiocarcinoma, who underwent percutaneous transhepatic cholangiography with biliary drainage
- Those with incomplete hospital records
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2023
Estimated Enrollment :
597 Patients enrolled
Trial Details
Trial ID
NCT06888401
Start Date
January 1 2017
End Date
March 1 2023
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kathmandu University School of Medical Sciences
Dhulikhel, Bagmati, Nepal, 45210